IE39872B1 - 1 3-oxygenated 8a-oestratrienes - Google Patents

1 3-oxygenated 8a-oestratrienes

Info

Publication number
IE39872B1
IE39872B1 IE1461/74A IE146174A IE39872B1 IE 39872 B1 IE39872 B1 IE 39872B1 IE 1461/74 A IE1461/74 A IE 1461/74A IE 146174 A IE146174 A IE 146174A IE 39872 B1 IE39872 B1 IE 39872B1
Authority
IE
Ireland
Prior art keywords
compounds
oestratrienes
oxygenated
oestraoligoene
gb1479934a
Prior art date
Application number
IE1461/74A
Other languages
English (en)
Other versions
IE39872L (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2336431A external-priority patent/DE2336431C2/de
Priority claimed from DE19742426777 external-priority patent/DE2426777A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of IE39872L publication Critical patent/IE39872L/xx
Publication of IE39872B1 publication Critical patent/IE39872B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0059Estrane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J15/00Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
IE1461/74A 1973-07-13 1974-07-11 1 3-oxygenated 8a-oestratrienes IE39872B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2336431A DE2336431C2 (de) 1973-07-13 1973-07-13 1.3-oxygenierte 8 alpha-Östratriene, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19742426777 DE2426777A1 (de) 1974-05-31 1974-05-31 1.3-oxygenierte 8 alpha-oestratriene

Publications (2)

Publication Number Publication Date
IE39872L IE39872L (en) 1975-01-13
IE39872B1 true IE39872B1 (en) 1979-01-17

Family

ID=25765510

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1461/74A IE39872B1 (en) 1973-07-13 1974-07-11 1 3-oxygenated 8a-oestratrienes

Country Status (18)

Country Link
JP (1) JPS5821639B2 (en, 2012)
AT (1) ATA575574A (en, 2012)
AU (1) AU477010B2 (en, 2012)
CA (1) CA1030951A (en, 2012)
CH (2) CH614217A5 (en, 2012)
CS (2) CS182260B2 (en, 2012)
DD (1) DD114066A5 (en, 2012)
DK (1) DK133051C (en, 2012)
ES (1) ES428226A1 (en, 2012)
FI (1) FI54131C (en, 2012)
FR (1) FR2236505B1 (en, 2012)
GB (1) GB1479934A (en, 2012)
HU (1) HU169791B (en, 2012)
IE (1) IE39872B1 (en, 2012)
IL (1) IL45259A (en, 2012)
NO (1) NO742546L (en, 2012)
SE (1) SE7409151L (en, 2012)
SU (1) SU626705A3 (en, 2012)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2551214C2 (de) * 1975-11-12 1984-07-12 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 1,3-oxygenierten 8α-Östratrienen
JPS5862734U (ja) * 1981-10-22 1983-04-27 日工株式会社 型枠支持サボ−ト
JPS59146759A (ja) * 1984-01-06 1984-08-22 株式会社日立製作所 自動ねじ込み装置
JPS60155376A (ja) * 1984-01-24 1985-08-15 松下電器産業株式会社 ナツト浮き検出装置
DE3710728A1 (de) * 1987-03-31 1988-10-13 Schering Ag Verfahren zur herstellung von 17(alpha)-ethinyl-17ss-hydroxy-18-methyl-4,15-estradien-3-on und die neuen zwischenprodukte fuer dieses verfahren
US6011024A (en) 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
US6476011B1 (en) 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
US6903084B2 (en) 1991-08-28 2005-06-07 Sterix Limited Steroid sulphatase inhibitors
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
RU2679625C1 (ru) * 2018-11-08 2019-02-12 Ильясов Шамиль Сионович ПРИМЕНЕНИЕ 3-О-СУЛЬФАМОИЛОКСИ-6-ОКСА-7β-МЕТИЛ-D-ГОМО-8α-ЭСТРА-1,3,5(10)-ТРИЕН-17а-ОНА ДЛЯ ЛЕЧЕНИЯ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ, ВКЛЮЧАЯ ТРИЖДЫ-НЕГАТИВНУЮ ФОРМУ, И СПОСОБ ЕГО ПОЛУЧЕНИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3436411A (en) * 1967-12-28 1969-04-01 American Home Prod Process for cleaving an a-ring ether group in 13-alkylgona (and 8-isogona)-1,3,5(10)-trienes and delta-7-,delta-8(9)-,and delta-8(9),14(15)-dehydro derivatives thereof

Also Published As

Publication number Publication date
SU626705A3 (ru) 1978-09-30
AU7112374A (en) 1976-01-15
JPS5821639B2 (ja) 1983-05-02
IE39872L (en) 1975-01-13
DK368074A (en, 2012) 1975-03-17
FR2236505B1 (en, 2012) 1977-07-08
IL45259A0 (en) 1974-10-22
SE7409151L (sv) 1975-01-14
ES428226A1 (es) 1976-07-16
DK133051B (da) 1976-03-15
CH609064A5 (en) 1979-02-15
CS182260B2 (en) 1978-04-28
AU477010B2 (en) 1976-10-14
NO742546L (en, 2012) 1975-02-10
CA1030951A (en) 1978-05-09
HU169791B (en) 1977-01-28
DD114066A5 (en, 2012) 1975-07-12
DK133051C (da) 1976-08-16
GB1479934A (en) 1977-07-13
ATA575574A (de) 1978-05-15
FI54131C (fi) 1978-10-10
FI54131B (fi) 1978-06-30
CH614217A5 (en) 1979-11-15
JPS5032160A (en, 2012) 1975-03-28
FI213974A7 (en, 2012) 1975-01-14
CS182300B2 (en) 1978-04-28
FR2236505A1 (en, 2012) 1975-02-07
IL45259A (en) 1977-10-31

Similar Documents

Publication Publication Date Title
IE39872B1 (en) 1 3-oxygenated 8a-oestratrienes
GB1476215A (en) Dibenzoxepin derivatives process for the preparation thereof and pharmaceutical compositions containing them
GB1530913A (en) Copying materials
GB1445956A (en) Esters of dihydroapovincaminic acid
IE40429L (en) 11ß-ALKYL STEROIDS OF THE ESTRANE SERIES.
GB1479362A (en) 3,17,18-trihydroxy-1,3,5(10)-oestratrienes and their derivatives
ES425088A1 (es) Procedimiento para preparar resinas acidas.
GB1277264A (en) 07-acetylgonanes and derivatives therefor
JPS57206616A (en) Menses inducer, feticidal or odynopoeia containing prostaglandin e1 analog
GB1325943A (en) Mono-acetyl derivatives of antibiotic sf 837 and sf 837-a2 substances and production thereof
ES436218A1 (es) Procedimiento para la obtencion de derivados de fenoxialca- nol.
GB1308849A (en) Process for the preparation of 6alpha-methyl-19-nor-pregnenes
ES400163A1 (es) Procedimiento para la preparacion de nuevos derivados de acido pregnanoico.
GB1366664A (en) 3 - /3 - cyanopropyl/ - cyclopenta /f/ /1/ benzopyrans and the preparation thereof
GB1495004A (en) Uv-curable resinous compounds and compositions
GB1303008A (en, 2012)
GB1198146A (en) 21-Ethers of 21-Hydroxy-delta<16>-Steroids of the Pregnane Series
ES422841A1 (es) Procedimiento de preparacion de esteres de 4-hidroxi-2,9- dioxatriciclo (4, 3, 03,7)-decanos.
GB1282703A (en) Salicil derivatives, the preparation thereof and antiparasitic compositions containing them
GB1435892A (en) Aluminium complexes of guaiphenesin
ES386351A1 (es) Un procedimiento para la preparacion de compuestos de 19- nortestosterona.
GB1260915A (en) PROCESS FOR THE MANUFACTURE OF (ANDROST-17beta-YL)-alpha-PYRONES
GB1415218A (en) Oxabicyclononane and process for the manufacture htereof
ES428016A1 (es) Un procedimiento para preparar nuevos aminoacidos.
ES318808A1 (es) Procedimiento para la fabricacion de nuevos alcoholes terciarios